After slamming through the spike high a week and a half ago, the IBB has now pulled back to test the breakout. Bottom line, that resistance has now become support.Most of the solar system is calling a bubble here, so its always good theater, and it makes every day interesting. A couple of things here can make you go to […]
NEW YORK (MarketWatch) — The current bull market is marking its sixth birthday, and a few slices of the stock market have more reason to celebrate than others.Who really deserves to whoop it up? Biotech and pharma ETFs, value ETFs that aim to find bargains, and ETFs targeting consumer-discretionary or retail stocks.The 10 ETFs that have performed best since the […]
Related ACHNAfter-Hours Movers Led By Bob Evans, Bazaarvoice And Smith & Wesson On TuesdayTop 5 Biotech Stocks That The Smart Money Doesn’t LikeAchillion Pharma updates guidance after Q4 results(Seeking Alpha)Barclays announced expanded coverage on seven biotech stocks Wednesday. Below are the new ratings and price targets along with comments from analyst Geoff Meacham.Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) was rated at […]
Myles Udland
Nov. 27, 2014, 8:00 AM
6,885
Bloomberg TelevisionGoldman Sachs’ David Kostin sees just modest gains for the S&P 500 in 2015.It’s still November, but Wall Street is already looking ahead to next year.Over the last few weeks, several outlooks for 2015 have rolled in, and so far, we’ve gotten outlooks from 8 of the biggest stock market gurus on Wall Street.Expectations […]
AppleSee AlsoThere’s Some Bad News Brewing For Apple And Samsung In ChinaTim Cook Took The ALS Ice Bucket Challenge And Called On Dr. Dre To Do It, TooApple Shareholders Are Suing The Company After Judge Finds ‘Ample Evidence’ Of A Conspiracy Against Employees
A new note from Barclays analystBen Reitzes says Apple is ready to make a “data and payments play” […]
